Equillium, Inc.EQNASDAQ
Loading
R&D Expense Growth Recovery in ProgressRecovering
Percentile Rank29
3Y CAGR-69.2%
5Y CAGR-66.7%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
-69.2%/yr
Annual compound
5Y CAGR
-66.7%/yr
Consistent
Percentile
P29
Within normal range
vs 5Y Ago
0x
Contraction
Streak
1 yr
Consecutive growthRecovering
| Period | Value |
|---|---|
| 2024 | 1.05% |
| 2023 | -1.35% |
| 2022 | 42.34% |
| 2021 | 36.09% |
| 2020 | 9.89% |
| 2019 | 256.87% |
| 2018 | 270.62% |
| 2017 | 0.00% |